In thyroid cancer, depletion of neuronal cell adhesion molecule (NrCAM) markedly impaired tumor growth and tumorigenic potential, and high-affinity NrCAM antibodies may offer a novel therapeutic option for NrCAM-positive malignancies [142]. Here, NRCAM is linked to neoplasm.